PTPRC and neoplasm: When the expression of PD-L1 was analyzed in tumor cells (CD45- cells) isolated from digested tumor, the level of PD-L1 was found to be around 1% on day 15 in both treatments, and in the case of the PBS-treated mice, the level increased up to 5% by day 30.